Association of plasma neurofilament light with neurodegeneration in patients with Alzheimer disease
(309)
Mattsson, Niklas
a,b
Andreasson, Ulf
c,d
Zetterberg, Henrik
c,d,e
Blennow, Kaj
c,d
Weiner, Michael W
f
Aisen, Paul
g
Toga, Arthur W
g
Petersen, Ronald
h
Jack, Clifford R
h
Jagust, William
i
Trojanowki, John Q
j
Shaw, Leslie M
j
Beckett, Laurel
k
Green, Robert C
l
Saykin, Andrew J
m
Morris, John C
n
Khachaturian, Zaven
cc
Sorensen, Greg
o
Carrillo, Maria
p
Kuller, Lew
q
Raichle, Marc
n
Holtzman, David
n
Paul, Steven
r
Davies, Peter
s
Fillit, Howard
t
Hefti, Franz
u
Mesulam, M Marcel
v
Potter, William
w
Snyder, Peter
x
Lilly, Eli
cc
Schwartz, Adam
cc
Montine, Tom
y
Thomas, Ronald G
z
Donohue, Michael
z
Walter, Sarah
z
Gessert, Devon
z
Sather, Tamie
z
Jiminez, Gus
z
Balasubramanian, Archana B
z
Mason, Jennifer
z
Sim, Iris
z
Harvey, Danielle
k
Bernstein, Matthew
h
Borowski, Bret
h
Gunter, Jeff
h
Senjem, Matt
h
Vemuri, Prashanthi
h
Jones, David
h
Kantarci, Kejal
h
Ward, Chad
h
Fox, Nick
aa
Thompson, Paul
ab
Schuff, Norbert
f
DeCarli, Charles
k
Landau, Susan
i
Koeppe, Robert A
ac
Foster, Norm
ad
Reiman, Eric M
ae
Chen, Kewei
ae
Mathis, Chet
q
Cairns, Nigel J
n
Franklin, Erin
n
Taylor Reinwald, Lisa
n
Lee, Virginia
j
Korecka, Magdalena
j
Figurski, Michal
j
Crawford, Karen
j
Neu, Scott
j
Foroud, Tatiana M
m
Shen, Li
m
Faber, Kelley
m
Kim, Sungeun
m
Nho, Kwangsik
m
Potkin, Steven
af
Thal, Lean
z
Albert, Marilyn
ag
Frank, Richard
ah
Hsiao, John
ai
Kaye, Jeffrey
aj
Quinn, Joseph
aj
Silbert, Lisa
aj
Lind, Betty
aj
Carter, Raina
aj
Dolen, Sara
aj
Schneider, Lon S
g
Pawluczyk, Sonia
g
Becerra, Mauricio
g
Teodoro, Liberty
g
Spann, Bryan M
g
Brewer, James
z
Vanderswag, Helen
z
Fleisher, Adam
z,ae
Heidebrink, Judith L
ac
Lord, Joanne L
ac
Mason, Sara S
h
Albers, Colleen S
h
Knopman, David
h
Johnson, Kris
h
Doody, Rachelle S
ak
Villanueva Meyer, Javier
ak
Pavlik, Valory
ak
Shibley, Victoria
ak
Chowdhury, Munir
ak
Rountree, Susan
ak
Dang, Mimi
ak
Stern, Yaakov
al
Honig, Lawrence S
al
Bell, Karen L
al
Ances, Beau
n
Carroll, Maria
n
Creech, Mary L
n
Mintun, Mark A
n
Schneider, Stacy
n
Oliver, Angela
n
Marson, Daniel
am
Geldmacher, David
am
Love, Marissa Natelson
am
Griffith, Randall
am
Clark, David
am
Brockington, John
am
Roberson, Erik
am
Grossman, Hillel
an
Mitsis, Effie
an
Shah, Raj C
ao
De Toledo Morrell, Leyla
ao
Duara, Ranjan
ap
Greig Custo, Maria T
ap
Barker, Warren
ap
Onyike, Chiadi
ag
D'Agostino, Daniel
ag
Kielb, Stephanie
ag
Sadowski, Martin
aq
Sheikh, Mohammed O
aq
Ulysse, Anaztasia
aq
Gaikwad, Mrunalini
aq
Doraiswamy, P Murali
ar
Petrella, Jeffrey R
ar
Borges Neto, Salvador
ar
Wong, Terence Z
ar
Coleman, Edward
ar
Arnold, Steven E
j
Karlawish, Jason H
j
Wolk, David A
j
Clark, Christopher M
j
Smith, Charles D
as
Jicha, Greg
as
Hardy, Peter
as
Sinha, Partha
as
Oates, Elizabeth
as
Conrad, Gary
as
Lopez, Oscar L
q
Oakley, Mary Ann
q
Simpson, Donna M
q
Porsteinsson, Anton P
at
Goldstein, Bonnie S
at
Martin, Kim
at
Makino, Kelly M
at
Ismail, M Saleem
at
Brand, Connie
at
Preda, Adrian
af
Nguyen, Dana
af
Womack, Kyle
au
Mathews, Dana
au
Quiceno, Mary
au
Levey, Allan I
av
Lah, James J
av
Cellar, Janet S
av
Burns, Jeffrey M
aw
Swerdlow, Russell H
aw
Brooks, William M
aw
Apostolova, Liana
ax
Tingus, Kathleen
ax
Woo, Ellen
ax
Silverman, Daniel H S
ax
Lu, Po H
ax
Bartzokis, George
ax
Graff Radford, Neill R
ay
Parfitt, Francine
ay
Poki Walker, Kim
ay
Farlow, Martin R
m
Hake, Ann Marie
m
Matthews, Brandy R
m
Brosch, Jared R
m
Herring, Scott
m
Van Dyck, Christopher H
az
Carson, Richard E
az
MacAvoy, Martha G
az
Varma, Pradeep
az
Chertkow, Howard
ba
Bergman, Howard
ba
Hosein, Chris
ba
Black, Sandra
bb
Stefanovic, Bojana
bb
Caldwell, Curtis
bb
Hsiung, Ging Yuek Robin
bc
Mudge, Benita
bc
Sossi, Vesna
bc
Feldman, Howard
bc
Assaly, Michele
bc
Finger, Elizabeth
bd,by
Pasternack, Stephen
bd
Rachisky, Irina
bd
Trost, Dick
bd
Kertesz, Andrew
bd,by
Bernick, Charles
be
Munic, Donna
be
Rogalski, Emily
v
Lipowski, Kristine
v
Weintraub, Sandra
v
Bonakdarpour, Borna
v
Kerwin, Diana
v
Wu, Chuang Kuo
v
Johnson, Nancy
v
Sadowsky, Carl
bf
Villena, Teresa
bf
Turner, Raymond Scott
bg
Johnson, Kathleen
bg
Reynolds, Brigid
bg
Sperling, Reisa A
l
Marshall, Gad
l
Yesavage, Jerome
bh
Taylor, Joy L
bh
Lane, Barton
bh
Rosen, Allyson
bh
Tinklenberg, Jared
bh
Sabbagh, Marwan N
bi
Belden, Christine M
bi
Jacobson, Sandra A
bi
Sirrel, Sherye A
bi
Kowall, Neil
bj
Killiany, Ronald
bj
Budson, Andrew E
bj
Norbash, Alexander
bj
Johnson, Patricia Lynn
bj
Obisesan, Thomas O
bk
Wolday, Saba
bk
Allard, Joanne
bk
Lerner, Alan
bl
Ogrocki, Paula
bl
Tatsuoka, Curtis
bl
Fatica, Parianne
bl
Fletcher, Evan
k
Maillard, Pauline
k
Olichney, John
k
Carmichael, Owen
k
Kittur, Smita
bm
Borrie, Michael
bn
Lee, T Y
bn
Bartha, Rob
bn
Johnson, Sterling
bo
Asthana, Sanjay
bo
Carlsson, Cynthia M
bo
Tariot, Pierre
ae
Burke, Anna
ae
Milliken, Ann Marie
ae
Trncic, Nadira
ae
Reeder, Stephanie
ae
Bates, Vernice
bp
Capote, Horacio
bp
Rainka, Michelle
bp
Scharre, Douglas W
bq
Kataki, Maria
bq
Kelley, Brendan
bq
Zimmerman, Earl A
br
Celmins, Dzintra
br
Brown, Alice D
br
Pearlson, Godfrey D
bs
Blank, Karen
bs
Anderson, Karen
bs
Flashman, Laura A
bt
Seltzer, Marc
bt
Hynes, Mary L
bt
Santulli, Robert B
bt
Sink, Kaycee M
bu
Gordineer, Leslie
bu
Williamson, Jeff D
bu
Garg, Pradeep
bu
Watkins, Franklin
bu
Ott, Brian R
bv
Tremont, Geoffrey
bv
Daiello, Lori A
bv
Salloway, Stephen
bw
Malloy, Paul
bw
Correia, Stephen
bw
Rosen, Howard J
f
Miller, Bruce L
f
Perry, David
f
Mintzer, Jacobo
bx
Spicer, Kenneth
bx
Bachman, David
bx
Pasternak, Stephen
by
Rachinsky, Irina
by
Rogers, John
by
Drost, Dick
by
Pomara, Nunzio
bz
Hernando, Raymundo
bz
Sarrael, Antero
bz
Schultz, Susan K
ca
Smith, Karen Ekstam
ca
Koleva, Hristina
ca
Nam, Ki Won
ca
Shim, Hyungsub
ca
Relkin, Norman
r
Chiang, Gloria
r
Lin, Michael
r
Ravdin, Lisa
r
Smith, Amanda
cb
Raj, Balebail Ashok
cb
Fargher, Kristin
cb
more..
|
-
1
-
-
84946048255
-
Revolutionizing Alzheimer's disease and clinical trials through biomarkers
-
Mattsson N, Carrillo MC, Dean RA, et al. Revolutionizing Alzheimer's disease and clinical trials through biomarkers. Alzheimers Dement (Amst). 2015;1(4):412-419.
-
(2015)
Alzheimers Dement (Amst)
, vol.1
, Issue.4
, pp. 412-419
-
-
Mattsson, N.1
Carrillo, M.C.2
Dean, R.A.3
-
2
-
-
77949423619
-
Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
-
Blennow K, Hampel H, Weiner M, Zetterberg H. Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nat Rev Neurol. 2010;6(3):131-144.
-
(2010)
Nat Rev Neurol
, vol.6
, Issue.3
, pp. 131-144
-
-
Blennow, K.1
Hampel, H.2
Weiner, M.3
Zetterberg, H.4
-
3
-
-
76849095847
-
The clinical use of structural MRI in Alzheimer disease
-
Frisoni GB, Fox NC, Jack CR Jr, Scheltens P, Thompson PM. The clinical use of structural MRI in Alzheimer disease. Nat Rev Neurol. 2010;6(2):67-77.
-
(2010)
Nat Rev Neurol
, vol.6
, Issue.2
, pp. 67-77
-
-
Frisoni, G.B.1
Fox, N.C.2
Jack, C.R.3
Scheltens, P.4
Thompson, P.M.5
-
4
-
-
76849116788
-
The use of PET in Alzheimer disease
-
Nordberg A, Rinne JO, Kadir A, Langstrom B. The use of PET in Alzheimer disease. Nat Rev Neurol. 2010;6(2):78-87.
-
(2010)
Nat Rev Neurol
, vol.6
, Issue.2
, pp. 78-87
-
-
Nordberg, A.1
Rinne, J.O.2
Kadir, A.3
Langstrom, B.4
-
5
-
-
84937758712
-
Amyloid biomarkers in Alzheimer's disease
-
Blennow K, Mattsson N, Scholl M, Hansson O, Zetterberg H. Amyloid biomarkers in Alzheimer's disease. Trends Pharmacol Sci. 2015;36(5):297-309.
-
(2015)
Trends Pharmacol Sci
, vol.36
, Issue.5
, pp. 297-309
-
-
Blennow, K.1
Mattsson, N.2
Scholl, M.3
Hansson, O.4
Zetterberg, H.5
-
6
-
-
84991224600
-
Neurofilament light: A dynamic cross-disease fluid biomarker for neurodegeneration
-
Zetterberg H. Neurofilament light: a dynamic cross-disease fluid biomarker for neurodegeneration. Neuron. 2016;91(1):1-3.
-
(2016)
Neuron
, vol.91
, Issue.1
, pp. 1-3
-
-
Zetterberg, H.1
-
7
-
-
84954224391
-
Association of cerebrospinal fluid neurofilament light concentration with Alzheimer disease progression
-
Zetterberg H, Skillback T, Mattsson N, et al; Alzheimer's Disease Neuroimaging Initiative. Association of cerebrospinal fluid neurofilament light concentration with Alzheimer disease progression. JAMA Neurol. 2016;73(1):60-67.
-
(2016)
JAMA Neurol
, vol.73
, Issue.1
, pp. 60-67
-
-
Zetterberg, H.1
Skillback, T.2
Mattsson, N.3
-
8
-
-
84884497586
-
Increased neurofilament light chain blood levels in neurodegenerative neurological diseases
-
Gaiottino J, Norgren N, Dobson R, et al. Increased neurofilament light chain blood levels in neurodegenerative neurological diseases. PLoS One. 2013;8(9):e75091.
-
(2013)
PLoS One
, vol.8
, Issue.9
, pp. e75091
-
-
Gaiottino, J.1
Norgren, N.2
Dobson, R.3
-
9
-
-
84991281277
-
Neurofilament light chain in blood and CSF as marker of disease progression in mouse models and in neurodegenerative diseases
-
Bacioglu M, Maia LF, Preische O, et al. Neurofilament light chain in blood and CSF as marker of disease progression in mouse models and in neurodegenerative diseases. Neuron. 2016;91(1): 56-66.
-
(2016)
Neuron
, vol.91
, Issue.1
, pp. 56-66
-
-
Bacioglu, M.1
Maia, L.F.2
Preische, O.3
-
10
-
-
84977653989
-
Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa
-
Kuhle J, Barro C, Andreasson U, et al. Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa. Clin Chem Lab Med. 2016; 54(10):1655-1661.
-
(2016)
Clin Chem Lab Med
, vol.54
, Issue.10
, pp. 1655-1661
-
-
Kuhle, J.1
Barro, C.2
Andreasson, U.3
-
11
-
-
84958936131
-
Plasma concentration of the neurofilament light protein (NFL) is a biomarker of CNS injury in HIV infection: A cross-sectional study
-
Gisslen M, Price RW, Andreasson U, et al. Plasma concentration of the neurofilament light protein (NFL) is a biomarker of CNS injury in HIV infection: a cross-sectional study. EBioMedicine. 2015;3:135-140.
-
(2015)
EBioMedicine
, vol.3
, pp. 135-140
-
-
Gisslen, M.1
Price, R.W.2
Andreasson, U.3
-
12
-
-
84977620914
-
Plasma neurofilament light chain predicts progression in progressive supranuclear palsy
-
Rojas JC, Karydas A, Bang J, et al. Plasma neurofilament light chain predicts progression in progressive supranuclear palsy. Ann Clin Transl Neurol. 2016;3(3):216-225.
-
(2016)
Ann Clin Transl Neurol
, vol.3
, Issue.3
, pp. 216-225
-
-
Rojas, J.C.1
Karydas, A.2
Bang, J.3
-
13
-
-
74949097405
-
Alzheimer's Disease Neuroimaging Initiative (ADNI): Clinical characterization
-
Petersen RC, Aisen PS, Beckett LA, et al. Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization. Neurology. 2010; 74(3):201-209.
-
(2010)
Neurology
, vol.74
, Issue.3
, pp. 201-209
-
-
Petersen, R.C.1
Aisen, P.S.2
Beckett, L.A.3
-
14
-
-
0021271971
-
Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
-
McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34(7):939-944.
-
(1984)
Neurology
, vol.34
, Issue.7
, pp. 939-944
-
-
McKhann, G.1
Drachman, D.2
Folstein, M.3
Katzman, R.4
Price, D.5
Stadlan, E.M.6
-
15
-
-
84988910596
-
Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia
-
Rohrer JD, Woollacott IOC, Dick KM, et al. Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia. Neurology. 2016;87(13):1329-1336.
-
(2016)
Neurology
, vol.87
, Issue.13
, pp. 1329-1336
-
-
Rohrer, J.D.1
Woollacott, I.O.C.2
Dick, K.M.3
-
16
-
-
65249159879
-
Cerebrospinal fluid biomarker signature in Alzheimer's Disease Neuroimaging Initiative subjects
-
Shaw LM, Vanderstichele H, Knapik-Czajka M, et al; Alzheimer's Disease Neuroimaging Initiative. Cerebrospinal fluid biomarker signature in Alzheimer's Disease Neuroimaging Initiative subjects. Ann Neurol. 2009;65(4):403-413.
-
(2009)
Ann Neurol
, vol.65
, Issue.4
, pp. 403-413
-
-
Shaw, L.M.1
Vanderstichele, H.2
Knapik-Czajka, M.3
-
17
-
-
41949137974
-
The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods
-
Jack CR Jr, Bernstein MA, Fox NC, et al. The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods. J Magn Reson Imaging. 2008;27(4):685-691.
-
(2008)
J Magn Reson Imaging
, vol.27
, Issue.4
, pp. 685-691
-
-
Jack, C.R.1
Bernstein, M.A.2
Fox, N.C.3
-
18
-
-
84951033618
-
Different definitions of neurodegeneration produce similar amyloid/neurodegeneration biomarker group findings
-
Jack CR Jr, Wiste HJ, Weigand SD, et al. Different definitions of neurodegeneration produce similar amyloid/neurodegeneration biomarker group findings. Brain. 2015;138(pt 12):3747-3759.
-
(2015)
Brain
, vol.138
, pp. 3747-3759
-
-
Jack, C.R.1
Wiste, H.J.2
Weigand, S.D.3
-
19
-
-
70349315265
-
Fully-automated white matter hyperintensity detection with anatomical prior knowledge and without FLAIR
-
Schwarz C, Fletcher E, DeCarli C, Carmichael O. Fully-automated white matter hyperintensity detection with anatomical prior knowledge and without FLAIR. Inf Process Med Imaging. 2009;21:239-251.
-
(2009)
Inf Process Med Imaging
, vol.21
, pp. 239-251
-
-
Schwarz, C.1
Fletcher, E.2
DeCarli, C.3
Carmichael, O.4
-
20
-
-
84862735174
-
Amyloid deposition hypometabolism and longitudinal cognitive decline
-
Landau SM, Mintun MA, Joshi AD, et al; Alzheimer's Disease Neuroimaging Initiative. Amyloid deposition, hypometabolism, and longitudinal cognitive decline. Ann Neurol. 2012;72 (4):578-586.
-
(2012)
Ann Neurol
, vol.72
, Issue.4
, pp. 578-586
-
-
Landau, S.M.1
Mintun, M.A.2
Joshi, A.D.3
-
21
-
-
85002757522
-
Neurofilament light in CSF and serum is a sensitive marker for axonal white matter injury in MS
-
Bergman J, Dring A, Zetterberg H, et al. Neurofilament light in CSF and serum is a sensitive marker for axonal white matter injury in MS. Neurol Neuroimmunol Neuroinflamm. 2016;3(5):e271.
-
(2016)
Neurol Neuroimmunol Neuroinflamm
, vol.3
, Issue.5
, pp. e271
-
-
Bergman, J.1
Dring, A.2
Zetterberg, H.3
-
22
-
-
84992386036
-
Plasma tau in Alzheimer disease
-
Mattsson N, Zetterberg H, Janelidze S, et al; ADNI Investigators. Plasma tau in Alzheimer disease. Neurology. 2016;87(17):1827-1835.
-
(2016)
Neurology
, vol.87
, Issue.17
, pp. 1827-1835
-
-
Mattsson, N.1
Zetterberg, H.2
Janelidze, S.3
-
23
-
-
84855304100
-
Cerebrospinal fluid levels of β-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia
-
Buchhave P, Minthon L, Zetterberg H, Wallin AK, Blennow K, Hansson O. Cerebrospinal fluid levels of β-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia. Arch Gen Psychiatry. 2012;69 (1):98-106.
-
(2012)
Arch Gen Psychiatry
, vol.69
, Issue.1
, pp. 98-106
-
-
Buchhave, P.1
Minthon, L.2
Zetterberg, H.3
Wallin, A.K.4
Blennow, K.5
Hansson, O.6
-
24
-
-
72049130805
-
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
-
Jack CR Jr, Knopman DS, JagustWJ, et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol. 2010;9(1):119-128.
-
(2010)
Lancet Neurol
, vol.9
, Issue.1
, pp. 119-128
-
-
Jack, C.R.1
Knopman, D.S.2
Jagust, W.J.3
-
25
-
-
84884127276
-
Preclinical Alzheimer's disease and its outcome: A longitudinal cohort study
-
Vos SJ, Xiong C, Visser PJ, et al. Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study. Lancet Neurol. 2013;12(10):957-965.
-
(2013)
Lancet Neurol
, vol.12
, Issue.10
, pp. 957-965
-
-
Vos, S.J.1
Xiong, C.2
Visser, P.J.3
-
26
-
-
79952808102
-
CSF biomarkers in neurodegenerative diseases
-
Mattsson N. CSF biomarkers in neurodegenerative diseases. Clin Chem Lab Med. 2011;49(3):345-352.
-
(2011)
Clin Chem Lab Med
, vol.49
, Issue.3
, pp. 345-352
-
-
Mattsson, N.1
-
27
-
-
84989947774
-
Cerebrospinal fluid tau neurogranin and neurofilament light in Alzheimer's disease
-
Mattsson N, Insel PS, Palmqvist S, et al; Alzheimer's Disease Neuroimaging Initiative. Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease. EMBO Mol Med. 2016;8(10):1184-1196.
-
(2016)
EMBO Mol Med
, vol.8
, Issue.10
, pp. 1184-1196
-
-
Mattsson, N.1
Insel, P.S.2
Palmqvist, S.3
|